DE60215864D1 - Behandlung von okularen neovaskularen erkrankungen - Google Patents

Behandlung von okularen neovaskularen erkrankungen

Info

Publication number
DE60215864D1
DE60215864D1 DE60215864T DE60215864T DE60215864D1 DE 60215864 D1 DE60215864 D1 DE 60215864D1 DE 60215864 T DE60215864 T DE 60215864T DE 60215864 T DE60215864 T DE 60215864T DE 60215864 D1 DE60215864 D1 DE 60215864D1
Authority
DE
Germany
Prior art keywords
treatment
ocular neovascular
neovascular diseases
diseases
ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60215864T
Other languages
English (en)
Other versions
DE60215864T2 (de
Inventor
Maria Margaron
Jing-Song Tao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novelion Therapeutics Inc
Original Assignee
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QLT Inc, Quadra Logic Technologies Inc filed Critical QLT Inc
Publication of DE60215864D1 publication Critical patent/DE60215864D1/de
Application granted granted Critical
Publication of DE60215864T2 publication Critical patent/DE60215864T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60215864T 2001-11-30 2002-11-29 Behandlung von okularen neovaskularen erkrankungen Expired - Fee Related DE60215864T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33528701P 2001-11-30 2001-11-30
US335287P 2001-11-30
PCT/CA2002/001859 WO2003045432A1 (en) 2001-11-30 2002-11-29 Treatment of neovascular ophthalmic disease

Publications (2)

Publication Number Publication Date
DE60215864D1 true DE60215864D1 (de) 2006-12-14
DE60215864T2 DE60215864T2 (de) 2007-05-31

Family

ID=23311112

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60215864T Expired - Fee Related DE60215864T2 (de) 2001-11-30 2002-11-29 Behandlung von okularen neovaskularen erkrankungen

Country Status (10)

Country Link
US (1) US20050074455A1 (de)
EP (1) EP1467761B1 (de)
AT (1) ATE344054T1 (de)
AU (1) AU2002351908A1 (de)
CA (1) CA2466864A1 (de)
DE (1) DE60215864T2 (de)
DK (1) DK1467761T3 (de)
ES (1) ES2275933T3 (de)
PT (1) PT1467761E (de)
WO (1) WO2003045432A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454976C (en) * 2001-07-26 2011-05-10 Santen Pharmaceutical Co., Ltd. Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient
US7479277B2 (en) * 2005-02-24 2009-01-20 Wisconsin Alumni Research Foundation Method for reducing intraocular pressure using integrin-linked kinase inhibitor
WO2010129775A1 (en) 2009-05-06 2010-11-11 University Of Virginia Patent Foundation Self-illuminated handheld lens for retinal examination and photography and related method thereof
IT201800005693A1 (it) * 2018-05-24 2019-11-24 Apparecchiatura per trattamenti biofotonici tissutali

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001622A (en) * 1995-12-21 1999-12-14 Sunnybrook Health Science Centre Integrin-linked kinase and its use
US6833436B2 (en) * 1997-05-21 2004-12-21 Children's Medical Center Corporation Short peptides which selectively modulate the activity of serine/threonine kinases
CA2245029A1 (en) * 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
WO2004073708A1 (en) * 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
US6177273B1 (en) * 1999-10-26 2001-01-23 Isis Pharmaceuticals Inc. Antisense modulation of integrin-linked kinase expression
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6436915B1 (en) * 2000-04-07 2002-08-20 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US6214813B1 (en) * 2000-04-07 2001-04-10 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US6420400B1 (en) * 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
KR100830859B1 (ko) * 2000-04-27 2008-05-21 아스텔라스세이야쿠 가부시키가이샤 이미다조피리딘 유도체 및 이를 함유하는 의약 조성물
US6403588B1 (en) * 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives

Also Published As

Publication number Publication date
WO2003045432A1 (en) 2003-06-05
DE60215864T2 (de) 2007-05-31
EP1467761A1 (de) 2004-10-20
ATE344054T1 (de) 2006-11-15
AU2002351908A1 (en) 2003-06-10
AU2002351908A8 (en) 2003-06-10
ES2275933T3 (es) 2007-06-16
US20050074455A1 (en) 2005-04-07
PT1467761E (pt) 2007-02-28
EP1467761B1 (de) 2006-11-02
WO2003045432A8 (en) 2003-08-14
DK1467761T3 (da) 2007-02-05
CA2466864A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
EA200400518A1 (ru) Способы лечения глазных неоваскулярных заболеваний
EA201000441A1 (ru) Водные офтальмологические препараты
WO2004004757A8 (en) Treatment for eye disorder
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
DK1239774T3 (da) Apparat til behandling af öjensygdomme
CY1108983T1 (el) Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων
NO20015969L (no) Forbedret skleral protese for behandling av presbyopi og andre öyesykdommer
EA200300560A1 (ru) Улучшенный способ лечения
DE502004010981D1 (de) Intraokulare linseneinrichtung zur verbesserung des sehvermögens bei netzhauterkrankungen
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
BRPI0517972A (pt) ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
DE60215864D1 (de) Behandlung von okularen neovaskularen erkrankungen
PT1131073E (pt) Uso de derivados de estaurosporina para o tratamento de doencas oculares neovasculares
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
BRPI0411427A (pt) formulações de agentes antiinflamatórios não-esteróides para o tratamento de angiogênese ocular patológica
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
WO2002015942A8 (en) Method for the identification of agents that inhibit or promote cataracts and uses thereof
PT1169026E (pt) Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular
RU2007119978A (ru) Способ лечения глаукомы в терминальной стадии заболевания
CY1114337T1 (el) Γονιδιακη μεταφορα με την μεσολαβηση φορεα λεντοϊων και χρησεις αυτης
RU2005109684A (ru) Способ лечения заболеваний заднего отдела глаза
UA86346C2 (ru) Способ лечения открытоугольной глаукомы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee